Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6319824B2 - - Google Patents
[go: Go Back, main page]

JPS6319824B2 - - Google Patents

Info

Publication number
JPS6319824B2
JPS6319824B2 JP55033168A JP3316880A JPS6319824B2 JP S6319824 B2 JPS6319824 B2 JP S6319824B2 JP 55033168 A JP55033168 A JP 55033168A JP 3316880 A JP3316880 A JP 3316880A JP S6319824 B2 JPS6319824 B2 JP S6319824B2
Authority
JP
Japan
Prior art keywords
blood
acid
serum
molding
spittoon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55033168A
Other languages
Japanese (ja)
Other versions
JPS56129859A (en
Inventor
Seiichiro Honda
Kazuhiko Kamyoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Chemical Co Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Priority to JP3316880A priority Critical patent/JPS56129859A/en
Publication of JPS56129859A publication Critical patent/JPS56129859A/en
Publication of JPS6319824B2 publication Critical patent/JPS6319824B2/ja
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は血液凝固促進作用を有する血液検査用
プラスチツク製容器に関し、詳しくは、被検者の
全血試料から遠心分離により血清や血漿を分離す
るために用いるプラスチツク製の有底の管状容
器、所謂スピツツに関する。 近年、検査技術の目ざましい進歩と相俟つて、
血清生化学検査、血清免疫学検査、血液学検査等
の血清検査が広く普及し、病気予防や早期診断に
大きく貢献するに至つている。血清検査は血液検
査の主体をなしており、検査に要する血清は、通
常、スピツツに採取した全血試料を凝固させた
後、遠心分離によつて比重の異なる血餅から分離
している。 従来、スピツツとしてはガラス製のものが使用
されてきたが、ガラス製スピツツは重いうえに、
全血試料の保存、運搬時や、遠心分離操作時に破
損しやすい等の欠点を有するため、近年、ポリス
チレン、ポリメチルメタクリレート、ポリエチレ
ン等の主に合成樹脂製スピツツが多く用いられて
いる。 このような合成樹脂製スピツツは破損し難い、
焼却しやすい等の利点を有する反面、ガラス製ス
ピツツに比較して、血液が凝固するまでに著しく
長時間を要するため、被検者から血液を採取後、
迅速に血清を得ることができなかつた。更に合成
樹脂製スピツツを用いた場合、生成する血餅成分
の収縮性が乏しく、その結果、血餅に血清が多量
に取り込まれて、血清の収量が小さく、また、分
取した血清中にしばしば血液が混入する問題があ
つた。 本発明者らは上記の問題を解決するために、血
液の凝固に及ぼすスピツツ内壁表面の影響を鋭意
研究した結果、内壁面にカルボキシル基を存在さ
せることによつて、血液凝固に要する時間を短縮
すると共に、血清成分と血餅成分を良好に分離す
ることができることを見出し、本発明を完成した
ものである。 即ち、本発明の血液凝固促進作用を有する血液
検査用プラスチツク製容器は、熱可塑性樹脂に一
塩基性カルボン酸を混合した後成形するか、もし
くは、スチレン−無水マレイン酸共重合樹脂成形
物の表面をアルカリ処理することにより、内壁表
面にカルボキシル基を存在させたことを特徴とす
るものである。 本発明における、熱可塑性樹脂に一塩基性カル
ボン酸を混合した後成形することにより、内壁表
面にカルボキシル基を存在させた、血液凝固促進
作用を有する血液検査用プラスチツク容器は、熱
可塑性樹脂としては、例えば、ポリスチレン、ポ
リメチルメタクリレート、ポリ塩化ビニル、ポリ
エチレン、ポリプロピレン、ポリ−4−メチルペ
ンテン−1、ポリエチレンテレフタレート、ポリ
ブチレンテレフタレート、スチレン−アクリロニ
トリル共重合体、スチレン−無水マレイン酸共重
合体、スチレン−アクリル酸共重合体、スチレン
−メチルメタクリレート共重合体、エチレン−プ
ロピレン共重合体、ポリビニルアルコールアセタ
ール化物、ポリビニルアルコールブチラール化物
等が使用される。 一塩基性カルボン酸としては、血清やその検査
に有害な影響を与えない限りは、脂肪族、脂環
族、芳香族を問わず、また、飽和、不飽和を問わ
ず、任意のものが用いられる。例えば、脂肪族飽
和カルボン酸としてはエナント酸、カプリル酸、
ペラルゴン酸、カプリン酸、ウンデシル酸、ラウ
リル酸、トリデシル酸、ミリスチン酸、ペンタデ
シル酸、パルミチン酸、ヘプタデシル酸、ステア
リン酸、ノナデカン酸、アラキン酸、ベヘン酸、
リグノセリン酸等、また、不飽和脂肪酸としてウ
ンデシレン酸、オレイン酸、エライジン酸、セト
レイン酸、エルカ酸等が用いられる。更に、芳香
族カルボン酸としては例えば、安息香酸、トルイ
ル酸、ジメチル安息香酸等が用いられる。以上の
ように、本発明においては種々の一塩基性カルボ
ン酸が用いられるが、特に、炭素数12〜22の範囲
にある脂肪酸が好ましく用いられる。酢酸やプロ
ピオン酸のような低級脂肪酸は溶血作用を有する
ので好ましくない。 本発明のスピツツは次の方法にて製造すること
ができる。成形材料としての熱可塑性樹脂に予め
一塩基性カルボン酸を一様に混合し、これを射出
成形、ブロー成形、圧縮成形、トランスフア成
形、真空成形、キヤスト成形等適宜の成形方法に
よつて成形するのである。この方法によれば、ス
ピツツの壁全体に表面だけでなく、厚さ方向にも
カルボン酸が分散されている。この方法による場
合、成形材料は、一塩基性カルボン酸をカルボキ
シル基換算で0.5重量%以上含むのが望ましい。 次に、本発明におけるスチレン−無水マレイン
共重合樹脂成形物の表面をアルカリ処理すること
により、内壁表面にカルボキシル基を存在させ
た、血液凝固促進作用を有する血液検査用プラス
チツク容器は、次のように製造される。 スチレン−無水マレイン酸共重合体をスピツツ
に成形した後、無水マレイン酸単位を加水分解す
る。この場合は、カルボキシル基はスピツツ管壁
表面にのみ存在することになる。この場合、スチ
レン−無水マレイン酸共重合体としては無水マレ
イン酸含量が3〜20モル%のものが適する。加水
分解は、例えば、スピツツをアルカリ水溶液に、
必要ならば加熱下に、浸漬した後、酸で中和処理
することにより行われ、加水分解の程度は適宜に
選ばれる。 本発明のスピツツは、以上のように、少なくと
もその内壁表面にカルボキシル基を有するため
に、スピツツ内に注入された全血試料は、カルボ
キシル基との接触によつてその血液凝固因子が迅
速に活性化せしめられ、血液凝固に要する時間が
著しく短縮される。更に、血小板、赤血球等の血
液中の細胞成分やフイブリン等の有形成分のスピ
ツツ壁面への付着が効果的に抑制され、その結
果、血液凝固後に、また、遠心分離後に血清上澄
成分と血餅成分との分離が完全となり、血清成分
への血餅成分の混入がなくなると共に、血餅成分
の収縮が十分に進行し、血清の収量が著しく大き
くなる。従つて、本発明のスピツツは、血液検査
用採血管、血液分離目的も有する採血用シリン
ジ、血清分離容器等の用途に好適に使用できる。 以下に本発明の実施例を挙げる。 実施例 1 表に示す組成の成形材料を射出成形し、外径17
mm、内径15mm、高さ170mmの有底スピツツを得た。
比較のために上記と同一寸法の市販スピツツを用
意した。 各スピツツに人新鮮血5c.c.注入後、25℃で放置
して、血清成分と分離した血餅成分が十分に収縮
し、血液が全く流動しなくなるまでに要した時間
を血液凝固時間として測定し、血液凝固を評価し
た。 次に、3000rpmで5分間遠心分離し、血清分離
状態を観察すると共に、上澄み血清をピペツトに
て採取し、その採取量を血清収量とした。結果を
市販スピツツの場合と併せて表に示すように、本
発明のスピツツによれば、血液凝固が速やかであ
り、血清分離状態も良好であることが明らかであ
る。 実施例 2 スチレン−無水マレイン酸共重合体(積水化成
品工業(株)ダイラーク#332)を射出成形し、実施
例1と同じ寸法のスピツツを製作した。このスピ
ツツを3%苛性ソーダ水溶液中に60分間室温にて
浸漬後、6%塩酸で中和処理し、乾燥した。この
スピツツについて実施例1と同様に試験したとこ
ろ、血液凝固時間は30分、血清分離状態は極めて
良好であり、血清収量は2.0
The present invention relates to a plastic container for blood tests that has a blood coagulation promoting effect, and more particularly, to a plastic container with a bottom that is used for separating serum and plasma from a whole blood sample of a subject by centrifugation. Regarding Spitz. In recent years, coupled with the remarkable progress in inspection technology,
Serum tests such as serum biochemistry tests, serum immunology tests, and hematology tests have become widely used and have greatly contributed to disease prevention and early diagnosis. Serological tests are the main body of blood testing, and the serum required for testing is usually obtained by coagulating a whole blood sample collected in a spittoon and then separating it from blood clots with different specific gravities by centrifugation. Traditionally, spitz made of glass have been used, but glass spitz are heavy and
In recent years, spits made of synthetic resins such as polystyrene, polymethyl methacrylate, and polyethylene have been widely used because they have drawbacks such as being easily damaged during storage and transportation of whole blood samples and during centrifugation operations. This type of synthetic resin spittoon is difficult to damage,
Although it has the advantage of being easy to incinerate, it takes a significantly longer time for blood to coagulate compared to glass spittoons, so after blood is collected from a subject,
Serum could not be obtained quickly. Furthermore, when a synthetic resin spittoon is used, the contractility of the blood clot components produced is poor, and as a result, a large amount of serum is incorporated into the blood clot, resulting in a small yield of serum. There was a problem with blood contamination. In order to solve the above problem, the present inventors conducted intensive research on the influence of the Spitz's inner wall surface on blood coagulation, and found that the presence of carboxyl groups on the inner wall surface shortened the time required for blood coagulation. At the same time, they discovered that serum components and blood clot components can be separated well, thereby completing the present invention. That is, the plastic container for blood tests having the action of promoting blood coagulation of the present invention can be produced by mixing a monobasic carboxylic acid with a thermoplastic resin and then molding it, or by molding it by molding a styrene-maleic anhydride copolymer resin. It is characterized by having carboxyl groups present on the inner wall surface by treating it with an alkali. The plastic container for blood tests of the present invention, which has a carboxyl group on the inner wall surface by mixing a monobasic carboxylic acid with a thermoplastic resin and then molding it, has a blood coagulation promoting effect. For example, polystyrene, polymethyl methacrylate, polyvinyl chloride, polyethylene, polypropylene, poly-4-methylpentene-1, polyethylene terephthalate, polybutylene terephthalate, styrene-acrylonitrile copolymer, styrene-maleic anhydride copolymer, styrene - Acrylic acid copolymer, styrene-methyl methacrylate copolymer, ethylene-propylene copolymer, polyvinyl alcohol acetal, polyvinyl alcohol butyral, etc. are used. Any monobasic carboxylic acid may be used, regardless of whether it is aliphatic, alicyclic, aromatic, or saturated or unsaturated, as long as it does not have a harmful effect on serum or its tests. It will be done. For example, aliphatic saturated carboxylic acids include enanthic acid, caprylic acid,
pelargonic acid, capric acid, undecylic acid, lauric acid, tridecylic acid, myristic acid, pentadecylic acid, palmitic acid, heptadecylic acid, stearic acid, nonadecanoic acid, arachidic acid, behenic acid,
Lignoceric acid, etc., and as unsaturated fatty acids, undecylenic acid, oleic acid, elaidic acid, cetoleic acid, erucic acid, etc. are used. Further, as the aromatic carboxylic acid, for example, benzoic acid, toluic acid, dimethylbenzoic acid, etc. are used. As described above, various monobasic carboxylic acids are used in the present invention, and fatty acids having a carbon number of 12 to 22 are particularly preferably used. Lower fatty acids such as acetic acid and propionic acid are not preferred because they have a hemolytic effect. The spittoon of the present invention can be manufactured by the following method. A monobasic carboxylic acid is uniformly mixed in advance with a thermoplastic resin as a molding material, and this is molded by an appropriate molding method such as injection molding, blow molding, compression molding, transfer molding, vacuum molding, cast molding, etc. That's what I do. According to this method, carboxylic acid is dispersed throughout the wall of the spittoon not only on the surface but also in the thickness direction. When using this method, the molding material preferably contains 0.5% by weight or more of a monobasic carboxylic acid in terms of carboxyl group. Next, the plastic container for blood tests of the present invention, which has carboxyl groups on the inner wall surface by alkali treatment of the surface of the styrene-maleic anhydride copolymer resin molded product and has a blood coagulation promoting effect, is as follows. Manufactured in After shaping the styrene-maleic anhydride copolymer into a spittoon, the maleic anhydride units are hydrolyzed. In this case, the carboxyl group will exist only on the surface of the Spitz tube wall. In this case, a styrene-maleic anhydride copolymer having a maleic anhydride content of 3 to 20 mol% is suitable. Hydrolysis can be carried out, for example, by adding Spitz to an alkaline aqueous solution,
If necessary, it is carried out by immersion under heating and then neutralization treatment with acid, and the degree of hydrolysis is appropriately selected. As described above, since the Spitz of the present invention has carboxyl groups at least on its inner wall surface, the blood coagulation factors of the whole blood sample injected into the Spitz are rapidly activated by contact with the carboxyl groups. The time required for blood clotting is significantly reduced. Furthermore, the adhesion of cellular components in the blood such as platelets and red blood cells and solid components such as fibrin to the spittoon wall is effectively suppressed, and as a result, after blood coagulation and after centrifugation, serum supernatant components and blood Separation from the clot components is complete, and contamination of the blood clot components with the serum components is eliminated, and the contraction of the blood clot components progresses sufficiently, resulting in a significantly large serum yield. Therefore, the spittoon of the present invention can be suitably used for applications such as blood collection tubes for blood tests, blood collection syringes that also serve the purpose of blood separation, and serum separation containers. Examples of the present invention are listed below. Example 1 A molding material having the composition shown in the table was injection molded, and an outer diameter of 17
A bottomed spittoon with an inner diameter of 15 mm and a height of 170 mm was obtained.
For comparison, a commercially available Spitz with the same dimensions as above was prepared. After injecting 5 c.c. of fresh human blood into each spittoon and leaving it at 25°C, the blood clotting time is the time required for the blood clot components separated from the serum components to sufficiently contract and the blood to stop flowing at all. and blood coagulation was evaluated. Next, the mixture was centrifuged at 3000 rpm for 5 minutes, the state of serum separation was observed, and the supernatant serum was collected with a pipette, and the collected amount was defined as the serum yield. As shown in the table together with the results for the commercially available Spitz, it is clear that the Spitz of the present invention has rapid blood coagulation and good serum separation. Example 2 A spittoon with the same dimensions as in Example 1 was manufactured by injection molding a styrene-maleic anhydride copolymer (Dylarc #332, manufactured by Sekisui Plastics Co., Ltd.). This spittoon was immersed in a 3% aqueous sodium hydroxide solution for 60 minutes at room temperature, neutralized with 6% hydrochloric acid, and dried. When this Spitz was tested in the same manner as in Example 1, the blood coagulation time was 30 minutes, the serum separation state was extremely good, and the serum yield was 2.0 minutes.

【表】 mlであつた。【table】 It was hot in ml.

Claims (1)

【特許請求の範囲】 1 熱可塑性樹脂に一塩基性カルボン酸を混合し
た後成形するか、もしくは、スチレン−無水マレ
イン酸共重合樹脂成形物の表面をアルカリ処理す
ることにより、内壁表面にカルボキシル基を存在
させたこと を特徴とする血液凝固促進作用を有する血液検査
用プラスチツク製容器。
[Scope of Claims] 1. Carboxyl groups are formed on the inner wall surface by mixing a monobasic carboxylic acid with a thermoplastic resin and then molding it, or by treating the surface of a styrene-maleic anhydride copolymer resin molded product with an alkali. 1. A plastic container for blood testing having a blood coagulation promoting effect, characterized by the presence of.
JP3316880A 1980-03-14 1980-03-14 Plastic container for blood inspection Granted JPS56129859A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3316880A JPS56129859A (en) 1980-03-14 1980-03-14 Plastic container for blood inspection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3316880A JPS56129859A (en) 1980-03-14 1980-03-14 Plastic container for blood inspection

Publications (2)

Publication Number Publication Date
JPS56129859A JPS56129859A (en) 1981-10-12
JPS6319824B2 true JPS6319824B2 (en) 1988-04-25

Family

ID=12379000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3316880A Granted JPS56129859A (en) 1980-03-14 1980-03-14 Plastic container for blood inspection

Country Status (1)

Country Link
JP (1) JPS56129859A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344611A (en) * 1993-06-14 1994-09-06 Becton, Dickinson And Company Vacuum actuated blood collection assembly including tube of clot-accelerating plastic
US5378431A (en) * 1993-06-14 1995-01-03 Becton, Dickinson And Company Dual pathway clotting enhancer for blood collection tube
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS587298B2 (en) * 1973-05-28 1983-02-09 株式会社クラレ Method for manufacturing medical molded products made of vinyl ester synthetic resin with hydrophilic surface
JPS5110631U (en) * 1974-07-10 1976-01-26
JPS5293398A (en) * 1976-02-02 1977-08-05 Toa Medical Electronics Preparing process of beaker for dilution of blood sample
JPS5414592U (en) * 1977-07-01 1979-01-30

Also Published As

Publication number Publication date
JPS56129859A (en) 1981-10-12

Similar Documents

Publication Publication Date Title
Robbins et al. An effect of antigen-antibody interaction on blood coagulation
DE2840768A1 (en) IMMUNOLOGICAL REAGENT
JPS6319824B2 (en)
JPS6367856B2 (en)
JPS6367656B2 (en)
JP2965359B2 (en) Blood test container
JP4337643B2 (en) Biochemical instruments
JPS6367859B2 (en)
Barrow et al. Factor VIII (AHF) activity of small size produced by succinylating plasma
JPS6085758A (en) Removal of lipoprotein using derived polyhydroxymethylene
JP3851442B2 (en) Blood coagulation promoter and blood test container
SU533376A1 (en) The method of obtaining Toxoplasma antigen
CN115494247B (en) Thrombin time quality control product and its preparation method and application
JPS6367658B2 (en)
DE2755559A1 (en) METHODS FOR CLEANING UP SERUM OR PLASMA
Krauss A Mucin Clot Reaction with Sea-Urchin Fertilizin
KR920001866B1 (en) Blood collecting tube
JPS58131566A (en) Lyophilized matter of red blood cell
JPH039421B2 (en)
CA1186219A (en) Method for determining allergic sensitivity
JP2000105237A (en) Method for determining the disease state of rheumatoid arthritis
JP3206329B2 (en) Blood test container
SU1737335A1 (en) Method of determining intravascular blood coagulation
JP3075595B2 (en) Method for producing endotoxin-free drugs
JPS6156133A (en) Removal of pyrogens